290 related articles for article (PubMed ID: 22536322)
1. Cell cycle gene networks are associated with melanoma prognosis.
Wang L; Hurley DG; Watkins W; Araki H; Tamada Y; Muthukaruppan A; Ranjard L; Derkac E; Imoto S; Miyano S; Crampin EJ; Print CG
PLoS One; 2012; 7(4):e34247. PubMed ID: 22536322
[TBL] [Abstract][Full Text] [Related]
2. Network-based co-expression analysis for exploring the potential diagnostic biomarkers of metastatic melanoma.
Wang LX; Li Y; Chen GZ
PLoS One; 2018; 13(1):e0190447. PubMed ID: 29377892
[TBL] [Abstract][Full Text] [Related]
3. Potential Prognostic Predictors and Molecular Targets for Skin Melanoma Screened by Weighted Gene Co-expression Network Analysis.
Chen S; Liu Z; Li M; Huang Y; Wang M; Zeng W; Wei W; Zhang C; Gong Y; Guo L
Curr Gene Ther; 2020; 20(1):5-14. PubMed ID: 32416689
[TBL] [Abstract][Full Text] [Related]
4. A novel lncRNA-miRNA-mRNA competitive endogenous RNA network for uveal melanoma prognosis constructed by weighted gene co-expression network analysis.
Yu H; Cheng Y; Li W; Li Z; Wu P; Qiu S; Zeng B; Huang B
Life Sci; 2020 Nov; 260():118409. PubMed ID: 32926921
[TBL] [Abstract][Full Text] [Related]
5. Targeted knockdown of polo-like kinase 1 alters metabolic regulation in melanoma.
Gutteridge RE; Singh CK; Ndiaye MA; Ahmad N
Cancer Lett; 2017 May; 394():13-21. PubMed ID: 28235541
[TBL] [Abstract][Full Text] [Related]
6. Coexpression network analysis identified that plakophilin 1 is associated with the metastasis in human melanoma.
Wang HZ; Wang F; Chen PF; Zhang M; Yu MX; Wang HL; Zhao Q; Liu J
Biomed Pharmacother; 2019 Mar; 111():1234-1242. PubMed ID: 30841437
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
8. Characterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis.
Wang S; Fan W; Wan B; Tu M; Jin F; Liu F; Xu H; Han P
PLoS One; 2017; 12(2):e0172498. PubMed ID: 28225791
[TBL] [Abstract][Full Text] [Related]
9. Multiple pro-tumorigenic functions of the human minor Histocompatibility Antigen-1 (HA-1) in melanoma progression.
Xu P; Ma J; Ma J; Zhang W; Guo S; Jian Z; Liu L; Wang G; Gao T; Zhu G; Li C
J Dermatol Sci; 2017 Nov; 88(2):216-224. PubMed ID: 28939173
[TBL] [Abstract][Full Text] [Related]
10. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
[TBL] [Abstract][Full Text] [Related]
11. A time course-dependent metastatic gene expression signature predicts outcome in human metastatic melanomas.
Chen R; Zhang G; Zhou Y; Li N; Lin J
Diagn Pathol; 2014 Aug; 9():155. PubMed ID: 25116415
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive upstream and downstream regulatory analyses identify miR-675-3p as a potential prognostic biomarker in melanoma.
Zhao CC; Guo H; Wang Y; Li JH
Hum Cell; 2021 Mar; 34(2):654-666. PubMed ID: 33400243
[TBL] [Abstract][Full Text] [Related]
13. microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.
Giles KM; Brown RA; Ganda C; Podgorny MJ; Candy PA; Wintle LC; Richardson KL; Kalinowski FC; Stuart LM; Epis MR; Haass NK; Herlyn M; Leedman PJ
Oncotarget; 2016 May; 7(22):31663-80. PubMed ID: 27203220
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of enhancer of rudimentary homolog expression attenuates proliferation, cell cycle and apoptosis of melanoma cells.
Xiao M; Tang N; Yan Y; Li Z; Shi S; He S; Chen Z; Cao K; Chen J; Zhou J; Chen X
Melanoma Res; 2021 Aug; 31(4):309-318. PubMed ID: 34193803
[TBL] [Abstract][Full Text] [Related]
15. Disturbed protein-protein interaction networks in metastatic melanoma are associated with worse prognosis and increased functional mutation burden.
Schramm SJ; Li SS; Jayaswal V; Fung DC; Campain AE; Pang CN; Scolyer RA; Yang YH; Mann GJ; Wilkins MR
Pigment Cell Melanoma Res; 2013 Sep; 26(5):708-22. PubMed ID: 23738911
[TBL] [Abstract][Full Text] [Related]
16. SMARCA4 promotes benign skin malignant transformation into melanoma through Adherens junction signal transduction.
Liu SR; Yang X; Qi L; Zhu Z; Ji YZ
Clin Transl Oncol; 2021 Mar; 23(3):591-600. PubMed ID: 32720055
[TBL] [Abstract][Full Text] [Related]
17. A gene expression signature of invasive potential in metastatic melanoma cells.
Jeffs AR; Glover AC; Slobbe LJ; Wang L; He S; Hazlett JA; Awasthi A; Woolley AG; Marshall ES; Joseph WR; Print CG; Baguley BC; Eccles MR
PLoS One; 2009 Dec; 4(12):e8461. PubMed ID: 20041153
[TBL] [Abstract][Full Text] [Related]
18. Network models of primary melanoma microenvironments identify key melanoma regulators underlying prognosis.
Song WM; Agrawal P; Von Itter R; Fontanals-Cirera B; Wang M; Zhou X; Mahal LK; Hernando E; Zhang B
Nat Commun; 2021 Feb; 12(1):1214. PubMed ID: 33619278
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis.
Ci C; Tang B; Lyu D; Liu W; Qiang D; Ji X; Qiu X; Chen L; Ding W
Int J Mol Med; 2019 Jan; 43(1):404-412. PubMed ID: 30431060
[TBL] [Abstract][Full Text] [Related]
20. Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis.
de Souza CF; Xander P; Monteiro AC; Silva AG; da Silva DC; Mai S; Bernardo V; Lopes JD; Jasiulionis MG
PLoS One; 2012; 7(9):e44800. PubMed ID: 22984562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
